AMGEN INC (AMGN) Earnings History

7 quarters held2/5 transcripts analyzed2/35 figures attested
Connect your agent
PeriodRevenueYoYNet incomeEPS (dil.)Filed
Q2 2026$10.1B+9.5%$2.4B$4.37Aug 4, 2026
LATESTEarnings filing (8-K)10-QFiled Aug 4, 2026, 4:03 PM ET
Earnings call · Aug 4, 2026deck
Q2 FY26YoY6M FY26
Revenue$10.1B1+9.5%–
Net income$2.4B+65.9%$4.2B
Op income$3.5B+32.3%–
EPS (dil.)$4.37+64.9%–
EPS (basic)$4.40+65.4%–
Gross margin29.5%-4.8pp
Op margin36.8%+6.5pp
Net margin23.6%+8.0pp
  1. [1] “Total revenues 10,054” view source

Guidance & outlook

Management guidance

Q2 2026

fy_current

eps_diluted
$15.80—$17.08

Special items & operational metrics

Operational metrics

Q2 2026
Average Diluted Shares (millions)
544
+0.6% YoY
Prior year: 541
shares
Q1 2026$8.6B+5.8%$1.8B$3.34Apr 30, 2026
10-QFiled Apr 30, 2026, 4:03 PM ET
Earnings call · Apr 30, 2026deck
Q1 FY26YoY
Revenue$8.6B1+5.8%
Net income$1.8B+5.1%
Op income$2.7B+126.3%
EPS (dil.)$3.34+4.4%
EPS (basic)––
Net margin21.1%-0.1pp
  1. [1] “For the first quarter, total revenues increased 6% to $8.6 billion in comparison to the first quarter of 2025.” view source
Q4 2025$499.0M–$1.3B$2.45Feb 3, 2026
Earnings filing (8-K)10-KFiled Feb 3, 2026, 4:03 PM ET
Earnings call · Feb 3, 2026transcriptprepared remarksQ&Adeck
Q4 FY25YoYFY25
Revenue$499.0M––
Net income$1.3B+112.6%$7.7B
Op income$2.7B––
EPS (dil.)$2.45+111.2%–
EPS (basic)$2.47+111.1%–
Op margin29.0%+2.5pp
Net margin13.5%+6.6pp
Q3 2025$9.6B+12.4%$3.2B$5.93Nov 4, 2025
Earnings filing (8-K)10-QFiled Nov 4, 2025, 3:04 PM ET
Earnings calldeck
Q3 FY25YoY9M FY25
Revenue$9.6B+12.4%–
Net income$3.2B+13.6%$6.4B
Op income$2.5B+23.4%$6.4B
EPS (dil.)$5.93+13.6%$11.77
EPS (basic)$5.98+13.5%$11.86
Op margin27.6%+2.5pp
Q2 2025$9.2B+9.4%$1.4B$2.65Aug 5, 2025
Earnings filing (8-K)10-QFiled Aug 5, 2025, 4:03 PM ET
Earnings calldeck
Q2 FY25YoY
Revenue$9.2B+9.4%
Net income$1.4B+92.0%
Op income$2.7B+39.1%
EPS (dil.)$2.65+92.0%
EPS (basic)$2.66+91.4%
Op margin30.3%+6.6pp
Net margin15.6%+6.7pp
Q4 2024––––Feb 4, 2025
10-KFiled Feb 4, 2025, 4:05 PM ET
Earnings calldeck
Q4 FY24YoY
Revenue––
Net income––
Op income––
EPS (dil.)––
EPS (basic)––
Q3 2024––––Oct 30, 2024
10-QFiled Oct 30, 2024, 4:06 PM ET
Earnings calldeck
Q3 FY24YoY
Revenue––
Net income––
Op income––
EPS (dil.)––
EPS (basic)––

IR event calendar

This company's IR event calendar has not been harvested yet — an empty result here does NOT mean the company has no IR events.

Filing coverage

51 filings indexed · 65,711 XBRL facts
FilingDatePeriodSectionsTables
10-Q2026-08-05–3891
8-K2026-08-04Q2 2026110
8-K2026-05-20–10
8-K2026-05-19–30
10-Q2026-05-01–38100
8-K2026-04-30Q1 2026110
8-K2026-04-22–10
DEF 14A2026-04-07–240
8-K2026-02-19–10
10-K2026-02-13FY 64174

Showing the latest 10 of 51 — the full set is in the API.

Related Research

Research

GLP-1 Drugs: What 977 SEC Filings Reveal

Analysis

The $1.7B Hidden Cost of Stryker's Acquisition Machine

Analysis

Four Forces Are Manufacturing Regeneron's EPS Growth as Operations Decline